Breaking Bad, Bacteria-Style

Move over, yeast. These genetically modified Escherichia coli bacteria can produce 300 times more thebaine—a morphine precursor—from the same amount of sugar.

AsianScientist (Mar. 1, 2016) – A common gut microbe could soon be offering us pain relief. Japanese bioengineers have tweaked Escherichia coli genes so that they can produce thebaine, a morphine precursor that can be modified to make painkillers.

The genetically modified E. coli bacteria produces 300 times more thebaine compared to a recently developed method involving yeast. The article was published in Nature Communications.

“Morphine has a complex molecular structure; because of this, the production of morphine and similar painkillers is expensive and time-consuming,” said study author Fumihiko Sato of Kyoto University.

“But with our E. coli, we were able to yield 2.1 milligrams of thebaine in a matter of days from roughly 20 grams of sugar, as opposed to 0.0064 mg with yeast.”

Morphine is extracted from poppy sap in a process that results in opiates such as thebaine and codeine. Other synthetic biologists have recently engineered the yeast genome so that it produces opiate alkaloids from sugar.

There were ethical concerns, however. There is the risk that the pain-killing molecules could be produced easily and in an unregulated manner, provided that one has access to the necessary yeast strain.

With E. coli, Sato said that such production risks are insignificant.

“Four strains of genetically modified E. coli are necessary to turn sugar into thebaine,” explained Sato. “E. coli are more difficult to manage and require expertise in handling. This should serve as a deterrent to unregulated production.”

In 2011, Sato and colleagues engineered E. coli to synthesize reticuline, another morphine precursor that appears earlier in the transformation process than thebaine.

In the new system, the team added genes from other bacteria and enzyme genes from opium poppies Coptis japonica, and Arabidopsis. The team credits the strong activity of enzymes in the new system for their success in making thebaine, and hopes to achieve further improvements.

“By adding another two genes, our E. coli were able to produce hydrocodone, which would certainly boost the practicality of this technique,” Sato said.

“With a few more improvements to the technique and clearance of pharmaceutical regulations, manufacturing morphine-like painkillers from microbes could soon be a reality.”



The article can be found at: Nakagawa et al. (2016) Total Biosynthesis of Opiates by Stepwise Fermentation Using Engineered Escherichia coli.

———

Source: Kyoto University.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist